For post-cholecystectomy patients, understanding these genetic factors alongside clinical biomarkers can support a more personalized conversation with your provider about GLP-1 candidacy and potential response patterns
Bottom line: Orforglipron could open the door for millions of people who want the benefits of GLP-1 medicine without the needle
Without deliberate effort, the appetite suppression from tirzepatide can override the body's natural thirst cues, potentially reducing creatine effectiveness and increasing kidney strain
Semaglutide vs tirzepatide is not a simple better-or-worse comparison
Gitanjali Srivastava, MD, medical director of obesity medicine at Vanderbilt University Medical Center, called the recommendations a step in the right direction. Its very consistent with all of the evidence weve had for many, many years, and Im glad the medical community is now recognizing the vast significance of treating obesity from a cardiology standpoint, Srivastava said
Abstract Background Alzheimers disease (AD) is the leading cause of dementia, characterized by a complex pathogenesis that complicates the development of effective treatments